Evidence map›Paper›PMID 36452120›Full record

ArticleCanadian journal of gastroenterology & hepatology2022

Comprehensive Analysis of N6-Methyladenosine (m

Duanrui Liu, Mingjie Yuan, Zongming Wang, Liping Sun, Yusong Fang, Xiaoli Ma, Lulu Zhang, Yuanxin Xing, Jingyu Zhu, Yunyun Liu and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of gastroenterology & hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Comprehensive Analysis of N6-Methyladenosine (mCanadian journal of gastroenterology & hepatology · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Duanrui LiuDepartment of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Mingjie YuanDepartment of Laboratory, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Zongming WangDepartment of Esophageal Surgery, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Liping SunDepartment of Infectious Diseases, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Yusong FangDepartment of Esophageal Surgery, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Xiaoli MaResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Lulu ZhangResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Yuanxin XingResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Jingyu ZhuDepartment of Gastroenterology, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Yunyun LiuResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Wenshuai ZhuResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Shuqin BaoResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.
Yanfei JiaResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.ORCID 0000-0002-0670-1604
Yunshan WangResearch Center of Basic Medicine, Jinan Central Hospital, Shandong First Medical University, Jinan 250013, China.ORCID 0000-0002-2776-185X
Jinan Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Gastroesophageal adenocarcinoma (GEA) is a high deadly and heterogeneous cancer. RNA N6-methyladenosine (m Methods: In this study, we examined the TME of GEA using assessments of the RNA-sequencing data focusing on the distinct m Results: We identified two distinct m Conclusion: Our work identified m

Indexed as

AdenocarcinomaTumor MicroenvironmentHumansImmunologic FactorsImmunotherapyMethylationPrognosisRNAImmunologic FactorsRNA

Identifiers

PMID36452120
PMCPMC9705116
OpenAlexW4309756661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.